Fund Holdings — Deep Track Capital, LP

Total Portfolio Value:
$3.09B
Total Bought:
$1.04B
Total Sold:
$460.67M
Net Transaction:
+$576.45M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Intra-Cellular Therapies Inc2,000,0002,000,0000$167.04M$263.84M8.54%+$96.80M
Guardant Health, Inc.(GH)6,419,5665,443,721-975,845$196.12M$231.90M7.51%+$35.78M
Dynavax Technologies Corp17,791,48617,791,4860$227.20M$230.76M7.47%+$3.56M
Immunovant, Inc.(IMVT)6,000,0009,500,000+3,500,000$148.62M$162.35M5.26%+$13.73M
Protagonist Therapeutics Inc1,000,0003,000,000+2,000,000$38.60M$145.08M4.70%+$106.48M
Ionis Pharmaceuticals, Inc.(IONS)1,933,9284,564,207+2,630,279$67.61M$137.70M4.46%+$70.09M
Akero Therapeutics Inc1,490,0003,210,270+1,720,270$41.45M$129.95M4.21%+$88.50M
Cytokinetics, Incorporated(CYTK)2,500,0003,073,853+573,853$117.60M$123.54M4.00%+$5.94M
Apellis Pharmaceuticals Inc
COM
4,274,9215,000,000+725,079$136.41M$109.35M3.54%-$27.06M
Ocular Therapeutix, Inc.(OCUL)12,836,28214,294,420+1,458,138$109.62M$104.78M3.39%-$4.84M
BridgeBio Pharma, Inc.(BBIO)819,1622,800,000+1,980,838$22.48M$96.80M3.13%+$74.32M
Tarsus Pharmaceuticals, Inc.(TARS)01,484,266+1,484,266$0$76.25M2.47%+$76.25M
Viridian Therapeutics, Inc.(VRDN)4,522,7415,380,449+857,708$86.70M$72.53M2.35%-$14.17M
Structure Therapeutics IncADS2,800,0004,100,000+1,300,000$75.94M$70.97M2.30%-$4.96M
89bio Inc6,478,2499,316,333+2,838,084$50.66M$67.73M2.19%+$17.07M
Nurix Therapeutics, Inc.(NRIX)3,000,0005,500,000+2,500,000$56.52M$65.34M2.12%+$8.82M
Geron Corporation(GERN)4,011,28738,176,251+34,164,964$14.20M$60.70M1.97%+$46.50M
Sarepta Therapeutics, Inc.(SRPT)0899,731+899,731$0$57.42M1.86%+$57.42M
Ultragenyx Pharmaceutical Inc.(RARE)653,5131,350,000+696,487$27.49M$48.88M1.58%+$21.39M
ANI Pharmaceuticals, Inc.(ANIP)649,042700,000+50,958$35.88M$46.87M1.52%+$10.99M
Dianthus Therapeutics, Inc.(DNTH)02,357,702+2,357,702$0$42.77M1.38%+$42.77M
Immunocore Holdings plcADS(IMCR)519,3761,411,402+892,026$15.32M$41.88M1.36%+$26.55M
Celldex Therapeutics, Inc.(CLDX)1,540,1322,000,000+459,868$38.92M$36.30M1.18%-$2.62M
Maze Therapeutics, Inc.(MAZE)03,269,126+3,269,126$0$35.99M1.17%+$35.99M
Amgen Inc.(AMGN)0113,035+113,035$0$35.22M1.14%+$35.22M
Xenon Pharmaceuticals Inc.(XENE)169,1321,000,000+830,868$6.63M$33.55M1.09%+$26.92M
Edgewise Therapeutics, Inc.(EWTX)710,4211,400,000+689,579$18.97M$30.80M1.00%+$11.83M
Metsera Inc01,094,408+1,094,408$0$29.79M0.96%+$29.79M
Vaxcyte, Inc.(PCVX)0750,000+750,000$0$28.32M0.92%+$28.32M
Autolus Therapeutics plcADS(AUTL)14,218,90317,849,482+3,630,579$33.41M$27.67M0.90%-$5.75M
Bicara Therapeutics Inc2,000,0002,000,0000$34.84M$26.06M0.84%-$8.78M
COMPASS Pathways plcADS(CMPS)08,859,648+8,859,648$0$25.34M0.82%+$25.34M
Tectonic Therapeutic, Inc.(TECX)01,401,938+1,401,938$0$24.83M0.80%+$24.83M
ABIVAX Société AnonymeADS(ABVX)3,579,2093,579,2090$26.20M$22.37M0.72%-$3.83M
MBX Biosciences, Inc.(MBX)3,018,9353,018,9350$55.64M$22.28M0.72%-$33.36M
GH Research PLC(GHRS)02,000,000+2,000,000$0$22.06M0.71%+$22.06M
Dyne Therapeutics, Inc.(DYN)2,000,0002,000,0000$47.12M$20.92M0.68%-$26.20M
Engene Holdings Inc
COM
4,557,5754,557,5750$30.31M$20.42M0.66%-$9.89M
Insmed Incorporated(INSM)0254,751+254,751$0$19.43M0.63%+$19.43M
Lakefront Biotherapeutics NVADR(LKFT)780,778741,068-39,710$21.47M$18.62M0.60%-$2.86M
Sage Therapeutics Inc02,038,845+2,038,845$0$16.21M0.52%+$16.21M
Terns Pharmaceuticals Inc5,576,5585,576,5580$30.89M$15.39M0.50%-$15.50M
Korro Bio, Inc.(KRRO)874,614874,6140$33.30M$15.23M0.49%-$18.07M
Oruka Therapeutics, Inc.(ORKA)750,0001,444,709+694,709$14.54M$14.82M0.48%+$280.2K
Mind Medicine Mindmed Inc2,816,5942,500,000-316,594$19.60M$14.63M0.47%-$4.98M
Upstream Bio, Inc.(UPB)1,000,0002,299,567+1,299,567$16.44M$14.07M0.46%-$2.37M
Olema Pharmaceuticals, Inc.(OLMA)3,442,8333,442,8330$20.07M$12.95M0.42%-$7.13M
Septerna, Inc.(SEPN)1,912,9291,912,9290$43.81M$11.08M0.36%-$32.73M
Novavax, Inc.(NVAX)2,000,0001,518,182-481,818$16.08M$9.73M0.32%-$6.35M
Cybin D/B/A Helus Pharma(HELP)1,529,9871,529,9870$13.49M$9.70M0.31%-$3.79M
Rapt Therapeutics Inc6,011,3806,011,3800$9.50M$7.33M0.24%-$2.16M
Pliant Therapeutics, Inc.(PLRX)5,972,2575,399,681-572,576$78.65M$7.29M0.24%-$71.37M
Avalo Therapeutics, Inc.(AVTX)867,000859,876-7,124$6.44M$6.89M0.22%+$445.8K
Bicycle Therapeutics PlcADS1,276,081767,016-509,065$17.87M$6.51M0.21%-$11.35M
Beam Therapeutics Inc.(BEAM)0315,765+315,765$0$6.17M0.20%+$6.17M
Invivyd, Inc.(IVVD)10,689,6039,722,254-967,349$4.74M$5.88M0.19%+$1.15M
Xencor, Inc.(XNCR)500,000549,439+49,439$11.49M$5.85M0.19%-$5.64M
Regulus Therapeutics Inc3,262,5643,262,5640$5.15M$5.71M0.18%+$554.6K
Inovio Pharmaceuticals, Inc.(INO)3,119,1623,119,1620$5.71M$5.08M0.16%-$623.8K
Rapport Therapeutics, Inc.(RAPP)0457,556+457,556$0$4.59M0.15%+$4.59M
Context Therapeutics Inc.(CNTX)7,419,3557,419,3550$7.79M$4.54M0.15%-$3.25M
Zura Bio LimitedCL A(ZURA)3,283,7833,283,7830$8.21M$4.24M0.14%-$3.97M
Aligos Therapeutics, Inc.(ALGS)244,110444,110+200,000$9.73M$3.66M0.12%-$6.06M
Spyre Therapeutics, Inc.(SYRE)219,015219,0150$5.10M$3.53M0.11%-$1.56M
Ikena Oncology Inc02,515,513+2,515,513$0$3.22M0.10%+$3.22M
OnKure Therapeutics, Inc.CL A(OKUR)523,989523,9890$4.51M$2.25M0.07%-$2.25M
Allakos Inc5,704,2827,232,701+1,528,419$6.90M$1.65M0.05%-$5.26M
Neurogene Inc.(NGNE)0116,660+116,660$0$1.37M0.04%+$1.37M
Climb Bio, Inc.(CLYM)1,040,1151,040,1150$1.87M$1.27M0.04%-$603.3K
4d Molecular Therapeutics In609,9000-609,900$3.40M$0—-$3.40M
Centessa Pharmaceuticals PlcADS1,350,0000-1,350,000$22.61M$0—-$22.61M
Genmab A/SADS(GMAB)2,000,0000-2,000,000$41.74M$0—-$41.74M
Harmony Biosciences Holdings, Inc.(HRMY)1,450,0000-1,450,000$49.89M$0—-$49.89M
Nektar Therapeutics(NKTR)1,975,9980-1,975,998$1.84M$0—-$1.84M
Neumora Therapeutics, Inc.(NMRA)4,000,0000-4,000,000$42.40M$0—-$42.40M
Springworks Therapeutics Inc3,460,7560-3,460,756$125.04M$0—-$125.04M
Verona Pharma PlcADS850,0000-850,000$39.47M$0—-$39.47M
Page 1 of 1
Deep Track Capital, LP — 13F Holdings — Q1 2025 | TickerTrail